David S. Grayzel's Net Worth
$97.5 Million
Who is David S. Grayzel?
David S. Grayzel has an estimated net worth of $97.5 Million. This is based on reported shares across multiple companies, which include Aerovate Therapeutics, Inc., and Surface Oncology, Inc..
SEC CIK
David S. Grayzel's CIK is 0001732786
Past Insider Trading and Trends
2021 was David S. Grayzel's most active year for acquiring shares with 7 total transactions. David S. Grayzel's most active month to acquire stocks was the month of May. 2020 was David S. Grayzel's most active year for disposing of shares, totalling 2 transactions. David S. Grayzel's most active month to dispose stocks was the month of November. 2021 saw David S. Grayzel paying a total of $20,739,090.96 for 10,129,765 shares, this is the most they've acquired in one year. In 2020 David S. Grayzel cashed out on 3,400,000 shares for a total of $44,540,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Aerovate Therapeutics, Inc. (AVTE) Snapshot price: $19.97
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -45.03% | -11.88K |
$28.15 | -$334,478.30 | 14.5K |
Apr 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
∞
| 3.1M |
$14.00 |
—
| 3.1M |
Jul 1 - Jul 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1 - Jun 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Surface Oncology, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -2.95M |
—
|
—
|
0
|
Sep 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4/A
| -36.59% | -1.70M |
$8.10 | -$13,770,000.00 | 2.95M |
Dec 17
| |||
Form 4
| -36.59% | -1.70M |
$18.10 | -$30,770,000.00 | 2.95M |
Dec 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
| +240.67% | 3.28M |
$15.00 |
—
| 4.65M |
Apr 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Homology Medicines, Inc. (FIXX) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||